全文获取类型
收费全文 | 4388篇 |
免费 | 247篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 166篇 |
妇产科学 | 92篇 |
基础医学 | 456篇 |
口腔科学 | 85篇 |
临床医学 | 338篇 |
内科学 | 1123篇 |
皮肤病学 | 43篇 |
神经病学 | 328篇 |
特种医学 | 293篇 |
外科学 | 551篇 |
综合类 | 51篇 |
一般理论 | 3篇 |
预防医学 | 203篇 |
眼科学 | 27篇 |
药学 | 229篇 |
中国医学 | 8篇 |
肿瘤学 | 600篇 |
出版年
2023年 | 30篇 |
2022年 | 54篇 |
2021年 | 82篇 |
2020年 | 55篇 |
2019年 | 69篇 |
2018年 | 104篇 |
2017年 | 83篇 |
2016年 | 81篇 |
2015年 | 118篇 |
2014年 | 125篇 |
2013年 | 184篇 |
2012年 | 280篇 |
2011年 | 258篇 |
2010年 | 134篇 |
2009年 | 110篇 |
2008年 | 190篇 |
2007年 | 209篇 |
2006年 | 181篇 |
2005年 | 185篇 |
2004年 | 190篇 |
2003年 | 174篇 |
2002年 | 155篇 |
2001年 | 132篇 |
2000年 | 119篇 |
1999年 | 119篇 |
1998年 | 67篇 |
1997年 | 64篇 |
1996年 | 70篇 |
1995年 | 57篇 |
1994年 | 44篇 |
1993年 | 37篇 |
1992年 | 58篇 |
1991年 | 70篇 |
1990年 | 70篇 |
1989年 | 74篇 |
1988年 | 80篇 |
1987年 | 63篇 |
1986年 | 72篇 |
1985年 | 66篇 |
1984年 | 39篇 |
1983年 | 43篇 |
1982年 | 18篇 |
1981年 | 19篇 |
1980年 | 13篇 |
1979年 | 31篇 |
1978年 | 16篇 |
1977年 | 27篇 |
1976年 | 19篇 |
1975年 | 20篇 |
1969年 | 13篇 |
排序方式: 共有4651条查询结果,搜索用时 11 毫秒
91.
Summary Humoral and cell-mediated disorders in Type 1 (insulin-dependent) diabetes suggest that an imbalance of immunoregulatory T-cell subsets exists. In 23 newly diagnosed (onset < 3 months) and 21 long-standing Type 1 diabetic patients, T lymphocyte subsets were analyzed using monoclonal antibodies (OKT3, OKT4, OKT8, OKM1). The newly diagnosed patients showed a reduction with a significant difference from healthy controls in total T cells (OKT3+: 58.1 ±8.5% versus 70.7±8.0%), helper/inducer cells (OKT4+: 33.8 ±7.0% versus 47.1 ±8.3%), suppressor/cytotoxic cells (OKT8+: 18.5±7.3% versus 32 ± 6.8%) and monocytes (OKM1+: 11.5±3.8% versus 19.9±5.2%) (p< 0.001). The long-standing diabetic patients also revealed a low number of immunoregulatory T cells compared with control subjects, although to a lesser extent (p< 0.01–0.05). The helper/suppressor ratio (OKT4+/OKT8+) was higher in newly diagnosed patients than in control subjects (2.2±1.3 versus 1.5±0.3; p< 0.02). When compared with 95% tolerance limits in the control subjects, the reduction of OKT8+ cells in the newly diagnosed diabetic patients appeared more marked: the mean (18.5%) coincided with the lower limit of normal subjects (18.3%). Ten of the newly diagnosed Type 1 diabetic patients had a value below the normal lower limit. Our data point to the occurrence of different immunoregulatory abnormalities in newly diagnosed Type 1 diabetic patients, especially in OKT8+ and OKT4+ cells. The imbalance in T lymphocyte subsets is further proof of the role of cellular autoimmunity in the pathogenesis of the early phases of Type 1 diabetes. 相似文献
92.
93.
Broglio F Prodam F Gottero C Destefanis S Me E Riganti F Giordano R Picu A Balbo M Van der Lely AJ Ghigo E Arvat E 《Clinical endocrinology》2004,60(6):699-704
OBJECTIVE: Acylated ghrelin, a gastric peptide, possesses a potent GH- but also significant ACTH/cortisol-releasing activity mediated by the activation of GH secretagogue receptors (GHS-R) at the hypothalamus-pituitary level. The physiological role of ghrelin in the control of somatotroph and corticotroph function is, however, largely unclear. Glucagon is known to induce a clear increase of GH, ACTH and cortisol levels in humans, at least after intramuscular administration. In fact, glucagon is considered to be a classical alternative to insulin-induced hypoglycaemia (ITT) for the combined evaluation of the function of GH and the hypothalamus-pituitary-adrenal (HPA) axis. We aimed to clarify whether ghrelin mediate the GH and corticotroph responses to intramuscular glucagon or ITT, which has recently been reported able to induce a surprising ghrelin decrease. SUBJECTS: To this aim we enrolled six normal young male subjects [age (mean +/- SD): 29.0 +/- 8.0 years, body mass index (BMI) 21.9 +/- 2.5 kg/m(2)]. DESIGN AND MEASUREMENTS: In all the subjects we studied ghrelin, GH, ACTH, cortisol and glucose levels after glucagon (GLU; 0.017 mg/kg intramuscularly), ITT (0.1 IU/kg insulin intravenously) or saline administration. RESULTS: Saline infusion was not followed by any significant variation in ghrelin, GH and glucose levels while ACTH and cortisol showed the expected spontaneous morning trend toward a decrease. GLU administration increased (P < 0.01) circulating GH, ACTH and cortisol as well as insulin and glucose levels. ITT induced an obvious increase (P < 0.01) of GH, ACTH and cortisol levels. The ITT-induced increases in GH and ACTH, but not cortisol, levels were higher (P < 0.01) than those after GLU. Circulating ghrelin levels were not modified by GLU. On the other hand, ghrelin levels underwent a transient reduction (P < 0.01) after insulin-induced hypoglycaemia. CONCLUSIONS: Ghrelin does not mediate the GH and ACTH responses to glucagon or to the ITT. In fact, ghrelin levels are not modified at all by glucagon and transiently decrease during the ITT. These findings support the assumption that ghrelin does not play a major role in the physiological control of somatotroph and corticotroph function. 相似文献
94.
Grottoli S Maccagno B Ramunni J Di Vito L Giordano R Gianotti L DeStefanis S Camanni F Ghigo E Arvat E 《Journal of endocrinological investigation》2002,25(5):420-425
Alprazolam (AL), a benzodiazepine which activates gamma-amino butyrric acid (GABA)-ergic receptors, exerts a clear inhibitory effect on the activity of the hypothalamo-pituitary-adrenal (HPA) axis and is able to markedly reduce the ACTH response to metyrapone-induced inhibition of glucocorticoid feedback. It has been suggested that its inhibitory action could be regulated by CRH or AVP mediated mechanisms. However, the effect of benzodiazepines on the HPA response to CRH or AVP is contradictory. It has been shown that benzodiazepines have specific receptors on the adrenal gland but it is unclear if they mediate biological effects in humans. In order to further clarify the mechanisms underlying the inhibitory effect of benzodiazepine on HPA axis in humans, we studied the effect of AL (0.02 mg/kg po at -90 min) or placebo in 7 healthy young volunteers (7 female, age: 26-34 yr; wt: 50-58 kg, BMI 20-22 kg/m2) on: 1) the ACTH and cortisol responses to hCRH (2.0 microg/kg iv at 0 min) or AVP (0.17 U/kg im at 0 min); 2) the cortisol, aldosterone and DHEA responses to ACTH 1-24 (0.06 and 250 microg iv at 0 and 60 min, respectively). After placebo, the ACTH and cortisol responses to hCRH (peaks, mean+/-SE: 29.8+/-4.4 pg/ml and 199.3+/-19.6 microg/l) were similar to those recorded after AVP (31.7+/-6.5 pg/ml and 164.8+/-18.0 microg/l); the cortisol response to 0.06 microg ACTH (190.4+/-11.8 microg/l) was similar to that recorded after hCRH and AVP but lower (p<0.01) than that after 250 microg ACTH (260.6+/-17.4 microg/l). AL did not modify the ACTH response to both hCRH (42.5+/-7.1 pg/ml) and AVP (33.3+/-2.7 pg/ml), which even showed a trend toward increase. AL also failed to significantly modify the cortisol response to both hCRH (156.3+/-12.7 microg/l) and AVP (119.4+/-14.5 microg/l), which, on the other hand, showed a trend toward decrease. The cortisol peaks after 0.06 microg ACTH were significantly reduced (p<0.02) by AL pre-treatment (115.0+/-7.7 microg/l) which, in turn, did not modify the cortisol response to the subsequent ACTH bolus (214.7+/-16.6 microg/l). The DHEA and aldosterone responses to all the ACTH doses were not significantly modified by AL. In conclusion, these data show that the HPA response to AVP as well as to hCRH is refractory to the inhibitory effect of AL which, in turn, blunts the cortisol response to low ACTH dose. These findings suggest that both CRH- and AVP-mediated mechanisms could underlie the CNS-mediated inhibitory effect of AL on HPA axis; in the meantime, these results suggest that benzodiazepines could also act on adrenal gland by blunting the sensitivity of the fasciculata zone to ACTH. 相似文献
95.
Anthony L Bui Rouselle F Lavado Elizabeth K Johnson Benjamin PC Brooks Michael K Freeman Casey M Graves Annie Haakenstad Benjamin Shoemaker Michael Hanlon Joseph L Dieleman 《Bulletin of the World Health Organization》2015,93(8):566-576D
Objective
To collect, compile and evaluate publicly available national health accounts (NHA) reports produced worldwide between 1996 and 2010.Methods
We downloaded country-generated NHA reports from the World Health Organization global health expenditure database and the Organisation for Economic Co-operation and Development (OECD) StatExtract website. We also obtained reports from Abt Associates, through contacts in individual countries and through an online search. We compiled data in the four main types used in these reports: (i) financing source; (ii) financing agent; (iii) health function; and (iv) health provider. We combined and adjusted data to conform with OECD’s first edition of A system of health accounts manual, (2000).Findings
We identified 872 NHA reports from 117 countries containing a total of 2936 matrices for the four data types. Most countries did not provide complete health expenditure data: only 252 of the 872 reports contained data in all four types. Thirty-eight countries reported an average not-specified-by-kind value greater than 20% for all data types and years. Some countries reported substantial year-on-year changes in both the level and composition of health expenditure that were probably produced by data-generation processes. All study data are publicly available at http://vizhub.healthdata.org/nha/.Conclusion
Data from NHA reports on health expenditure are often incomplete and, in some cases, of questionable quality. Better data would help finance ministries allocate resources to health systems, assist health ministries in allocating capital within the health sector and enable researchers to make accurate comparisons between health systems. 相似文献96.
Borchiellini Alessandra Castaman Giancarlo Feola Giulio Ferretti Antonietta Giordano Paola Luciani Matteo Malcangi Giuseppe Margaglione Maurizio Molinari Angelo Claudio Pollio Berardino Rocino Angiola Santoro Cristina Schiavulli Michele Zanon Ezio 《Journal of thrombosis and thrombolysis》2022,53(4):934-944
Journal of Thrombosis and Thrombolysis - rVIII-SingleChain is indicated for treatment and prophylaxis of bleeding in patients with haemophilia A (HA). The safety and efficacy of rVIII-SingleChain... 相似文献
97.
Guajardo Emmanuel Giordano Thomas P. Westbrook Robert A. Black William C. Njue-Marendes Sarah Dang Bich N. 《AIDS and behavior》2022,26(6):1880-1891
AIDS and Behavior - We conducted a prospective cohort study of 450 patients new to an HIV clinic in Houston, TX, to examine the roles of life stressors and initial care experiences in predicting... 相似文献
98.
Lucia Taramasso Paolo Bonfanti Elena Ricci Paolo Maggi Giancarlo Orofino Nicola Squillace Barbara Menzaghi Giordano Madeddu Chiara Molteni Francesca Vichi Erika Riguccini Annalisa Saracino Carmen Santoro Marta Guastavigna Daniela Francisci Antonio Di Biagio Giuseppe Vittorio De Socio 《HIV medicine》2022,23(1):70-79
99.
Di Candia Domenico Boracchi Michele Ciprandi Barbara Giordano Gaia Zoja Riccardo 《International journal of legal medicine》2022,136(5):1291-1296
International Journal of Legal Medicine - Synthetic cathinones are a class of psychoactive drugs that have become, in recent years, of quite common observation in medical and toxicological forensic... 相似文献
100.
C Vigorito A Giordano E Casaburi P Ferraro B Maurelli S Rumolo P Silvestri F Rengo 《Bibliotheca cardiologica》1989,(44):40-5; discussion 45-6